NCT02016573

Renal Denervation for Uncontrolled Hypertension

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Baker Heart and Diabetes Institute · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This is a study investigating the safety and usefulness of the Renal Denervation Procedure in reducing high blood pressure in people whose blood pressure is not adequately controlled despite already being treated with 2 blood pressure lowering drugs. This study is designed to compare the effects renal denervation to a usual care group.

Detailed description

This is a phase 4 randomised control trial of renal denervation for the treatment of uncontrolled hypertension. Previous studies have shown that the renal denervation procedure is safe and effective in reducing blood pressure. A total of 100 participants with uncontrolled blood pressure, treated with two blood pressure lowering medications will be recruited into the study. Patients will be assigned to one of two groups. Participants in Group 1 will be assigned to undergo the renal denervation procedure. Participants in group 2 will undergo usual care, receiving additional antihypertensive medication in an attempt to reach blood pressure targets. The duration of this study is 36 months.

Conditions

• Hypertension

Interventions

Type	Name	Description
DEVICE	Renal Denervation	Renal Denervation Catheter

Timeline

• Start date: 2013-12-01
• Primary completion: 2015-04-01
• Completion: 2015-04-01
• First posted: 2013-12-20
• Last updated: 2018-11-06